Related Experiment Video
Updated: Apr 3, 2026

03:53
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
1.4K
Role of Tissue Factor in the Coagulation Network
Giovanni Cimmino1, Giovanni Ciccarelli1, Paolo Golino1
1Division of Cardiology, Department of Cardio-Thoracic Sciences, Second University of Naples, Naples, Italy.
Seminars in Thrombosis and Hemostasis
|September 27, 2015
Summary
Tissue factor (TF) initiates blood clots, but circulating TF forms can worsen thrombosis and inflammation. TF also plays roles beyond coagulation, impacting cell signaling and tumor growth.
Area of Science:
- Biochemistry
- Hematology
- Oncology
Background:
- Tissue factor (TF) is traditionally viewed as the primary initiator of blood coagulation and thrombosis upon vascular injury.
- TF exposure from atherosclerotic plaques is linked to acute coronary syndromes and plaque-related thrombosis.
Purpose of the Study:
- To explore the evolving understanding of TF's role beyond vessel wall exposure.
- To investigate the impact of circulating TF pools on thrombotic events and inflammation.
- To highlight TF's multifaceted biological functions, including intracellular signaling and cancer progression.
Main Methods:
- Review of existing literature on TF biology and its role in thrombosis and inflammation.
- Analysis of recent evidence regarding circulating TF forms (cell-associated, microparticle-bound, soluble).
- Examination of TF's non-hemostatic functions, including signaling pathways.
Main Results:
- Discoveries reveal diverse circulating TF pools that can augment thrombosis initiated by vessel wall TF.
- Increased circulating TF activity correlates with more severe thrombotic events and potentiated inflammation.
- TF is implicated in inflammatory processes and has non-coagulant roles in cell signaling, proliferation, angiogenesis, and metastasis.
Conclusions:
- The understanding of TF's role in thrombosis has expanded beyond its surface-bound function.
- Circulating TF contributes significantly to thrombotic risk and inflammatory responses.
- TF possesses complex biological activities extending into cellular processes and disease progression, including cancer.
More Related Videos
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
15.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.4K
Coagulation
12.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
12.0K
Coagulation
1.7K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.7K
Clot Retraction and Fibrinolysis
10.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Introduction to Hemostasis
17.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
17.0K

